Follow
Tu'uhevaha Kaitu'u-Lino
Title
Cited by
Cited by
Year
Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation
RL Jones, NJ Hannan, TJ Kaitu’u, J Zhang, LA Salamonsen
The Journal of Clinical Endocrinology & Metabolism 89 (12), 6155-6167, 2004
3532004
Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction
FC Brownfoot, R Hastie, NJ Hannan, P Cannon, L Tuohey, LJ Parry, ...
American journal of obstetrics and gynecology 214 (3), 356. e1-356. e15, 2016
2362016
Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia
FC Brownfoot, S Tong, NJ Hannan, NK Binder, SP Walker, P Cannon, ...
Hypertension 66 (3), 687-697, 2015
1822015
Claudin-11 expression and localisation is regulated by androgens in rat Sertoli cells in vitro
J Tu’uhevaha, P Sluka, CFH Foo, PG Stanton
Reproduction 133 (6), 1169-1179, 2007
1542007
Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction
K Onda, S Tong, S Beard, N Binder, M Muto, SN Senadheera, L Parry, ...
Hypertension 69 (3), 457-468, 2017
1382017
Neutrophil depletion retards endometrial repair in a mouse model
TJ Kaitu’u-Lino, NB Morison, LA Salamonsen
Cell and tissue research 328 (1), 197-206, 2007
1102007
Clinical tools and biomarkers to predict preeclampsia
TM MacDonald, SP Walker, NJ Hannan, S Tong, J Tu'uhevaha
EBioMedicine 75, 2022
1052022
Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity
KR Palmer, TJ Kaitu’u-Lino, R Hastie, NJ Hannan, L Ye, N Binder, ...
Hypertension 66 (6), 1251-1259, 2015
982015
Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis
KR Palmer, S Tong, TJ Kaitu'u-Lino
MHR: Basic science of reproductive medicine 23 (2), 69-78, 2017
952017
MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin
J Tu'uhevaha, KR Palmer, CL Whitehead, E Williams, M Lappas, S Tong
The American journal of pathology 180 (3), 888-894, 2012
912012
Matrix metalloproteinases in endometrial breakdown and repair: functional significance in a mouse model
TJ Kaitu’u, J Shen, J Zhang, NB Morison, LA Salamonsen
Biology of reproduction 73 (4), 672-680, 2005
862005
Estrogen is not essential for full endometrial restoration after breakdown: lessons from a mouse model
TJ Kaitu’u-Lino, NB Morison, LA Salamonsen
Endocrinology 148 (10), 5105-5111, 2007
842007
Paternal obesity in a rodent model affects placental gene expression in a sex-specific manner
NK Binder, SA Beard, TJ Kaitu’u-Lino, S Tong, NJ Hannan, DK Gardner
Reproduction 149 (5), 435-444, 2015
812015
Role of label-retaining cells in estrogen-induced endometrial regeneration
RWS Chan, T Kaitu’u-Lino, CE Gargett
Reproductive sciences 19 (1), 102-114, 2012
732012
Reepithelialization of the uterine surface arises from endometrial glands: evidence from a functional mouse model of breakdown and repair
TJ Kaitu'u-Lino, L Ye, CE Gargett
Endocrinology 151 (7), 3386-3395, 2010
722010
Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia
S Tong, J Tu’uhevaha, R Hastie, F Brownfoot, C Cluver, N Hannan
American journal of obstetrics and gynecology 226 (2), S1157-S1170, 2022
692022
Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial …
FC Brownfoot, S Tong, NJ Hannan, R Hastie, P Cannon, TJ Kaitu’u-Lino
BMC pregnancy and childbirth 16, 1-8, 2016
682016
Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies
TJ Kaitu’u-Lino, S Pattison, L Ye, L Tuohey, P Sluka, J MacDiarmid, ...
Endocrinology 154 (2), 911-919, 2013
672013
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction–implications as a preeclampsia treatment
NJ Hannan, FC Brownfoot, P Cannon, M Deo, S Beard, TV Nguyen, ...
Scientific reports 7 (1), 1819, 2017
632017
Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin
J Tu’uhevaha, S Tong, S Beard, R Hastie, L Tuohey, F Brownfoot, K Onda, ...
Pregnancy Hypertension: An International Journal of Women's Cardiovascular …, 2014
632014
The system can't perform the operation now. Try again later.
Articles 1–20